As a dual-specificity DNA-binding transcription factor, Kaiso functions as either a transcriptional activator or repressor (Daniel, 2007; Iioka et al., 2009; Pierre et al., 2019), which further adds to the complexity of its role in normal vertebrate development and disease states such as IBD and colon cancer. This evidence concerns the gene ZBTB33 and inflammatory bowel disease.